Management of acute and chronic aortic disease during the COVID-19 pandemic-Results from a web-based ad hoc platform.
Martin CzernyJos van den BergRoberto ChiesaMichael JacobsStephan JakobHans-Jörg JenniRoberto LorussoDavide PaciniEduardo QuintanaBartosz RylskiKlaus StaierNikolaos TsilimparisThomas WyssRoman GottardiJuerg SchmidliPublished in: Journal of cardiac surgery (2020)
The current COVID-19 pandemic has-besides the stoppage of elective referrals-also led to a decrease of referrals of acute aortic syndromes in many settings. The reluctance of patients seeking medical help seems to be a major driver. The number of patients, who have been postponed due to the provisioning of ICU resources but having experienced aortic rupture in the waiting period, is still low. Further, studies are needed to learn more about the influence that the COVID-19 pandemic has on the treatment of patients with acute and chronic aortic disease.
Keyphrases
- end stage renal disease
- aortic dissection
- aortic valve
- newly diagnosed
- chronic kidney disease
- left ventricular
- pulmonary artery
- liver failure
- prognostic factors
- healthcare
- peritoneal dialysis
- intensive care unit
- mental health
- heart failure
- drug induced
- pulmonary hypertension
- acute respiratory distress syndrome
- patient reported
- extracorporeal membrane oxygenation
- atrial fibrillation